378 related articles for article (PubMed ID: 32938734)
1. Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth Microdilution.
Morris CP; Bergman Y; Tekle T; Fissel JA; Tamma PD; Simner PJ
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32938734
[TBL] [Abstract][Full Text] [Related]
2. Cefiderocol Antimicrobial Susceptibility Testing Considerations: the Achilles' Heel of the Trojan Horse?
Simner PJ; Patel R
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32727829
[TBL] [Abstract][Full Text] [Related]
3. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.
Matuschek E; Longshaw C; Takemura M; Yamano Y; Kahlmeter G
J Antimicrob Chemother; 2022 May; 77(6):1662-1669. PubMed ID: 35289853
[TBL] [Abstract][Full Text] [Related]
4. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales.
Bonnin RA; Emeraud C; Jousset AB; Naas T; Dortet L
Clin Microbiol Infect; 2022 Aug; 28(8):1156.e1-1156.e5. PubMed ID: 35533970
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Variability in Interpretation of Disk Diffusion Testing for Cefiderocol Using Different Brands of Mueller-Hinton Agar.
Potter RF; Wallace MA; Muenks CE; Alvarado K; Yarbrough ML; Burnham CD
J Appl Lab Med; 2023 May; 8(3):523-534. PubMed ID: 36738243
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii carrying various β-lactamase encoding genes.
Uskudar-Guclu A; Danyildiz S; Mirza HC; Akcil Ok M; Basustaoglu A
Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1171-1179. PubMed ID: 38652417
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against
Liu Y; Ding L; Han R; Zeng L; Li J; Guo Y; Hu F
Microbiol Spectr; 2023 Dec; 11(6):e0535522. PubMed ID: 37855593
[TBL] [Abstract][Full Text] [Related]
8.
Shortridge D; Streit JM; Mendes R; Castanheira M
Microbiol Spectr; 2022 Apr; 10(2):e0271221. PubMed ID: 35262394
[TBL] [Abstract][Full Text] [Related]
9. Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa.
Mojica MF; De La Cadena E; Hernández-Gómez C; Correa A; Appel TM; Pallares CJ; Villegas MV
J Glob Antimicrob Resist; 2020 Jun; 21():391-395. PubMed ID: 32004722
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Agar Dilution to Broth Microdilution for Testing
Albano M; Karau MJ; Schuetz AN; Patel R
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32967901
[TBL] [Abstract][Full Text] [Related]
11. Analysis of In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Gram-Negative Bacilli by Broth Microdilution and Disk Diffusion Method: A Single-Center Study in Odisha, India.
Nayak G; Behera B; Mohanty S; Kar P; Jena J
Infect Drug Resist; 2022; 15():5887-5897. PubMed ID: 36237292
[TBL] [Abstract][Full Text] [Related]
12. Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant Enterobacterales.
Fouad A; Simner PJ; Nicolau DP; Asempa TE
J Clin Microbiol; 2024 Jun; 62(6):e0152023. PubMed ID: 38712928
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of
García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745
[TBL] [Abstract][Full Text] [Related]
14.
Hackel MA; Tsuji M; Yamano Y; Echols R; Karlowsky JA; Sahm DF
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158270
[TBL] [Abstract][Full Text] [Related]
15. Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: a nationwide proficiency study.
Fernández-Cuenca F; Tomás M; Caballero-Moyano FJ; Bou G; Pascual Á;
J Antimicrob Chemother; 2018 Mar; 73(3):692-697. PubMed ID: 29244131
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Commercial Broth Microdilution Panel for Colistin Susceptibility Testing of Clinical Isolates of Escherichia coli and Klebsiella pneumoniae.
Mirza HC; Bıçakçıgil A; Liste Ü; Sancak B
Clin Lab; 2021 May; 67(5):. PubMed ID: 33978373
[TBL] [Abstract][Full Text] [Related]
17.
Hackel MA; Tsuji M; Yamano Y; Echols R; Karlowsky JA; Sahm DF
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630181
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014-2018 studies in Spain.
Cercenado E; Cardenoso L; Penin R; Longshaw C; Henriksen AS; Pascual A
J Glob Antimicrob Resist; 2021 Sep; 26():292-300. PubMed ID: 34274538
[TBL] [Abstract][Full Text] [Related]
19. In-Vitro Efficacy of Cefiderocol in Carbapenem-Non-Susceptible Gram-Negative Bacilli of Different Genotypes in Sub-Region of North Rhine Westphalia, Germany.
Ghebremedhin B; Ahmad-Nejad P
Pathogens; 2021 Sep; 10(10):. PubMed ID: 34684208
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal.
Gijón D; García-Castillo J; Fernández-López MC; Bou G; Siller M; Calvo-Montes J; Pitart C; Vila J; Torno N; Gimeno C; Cruz H; Ramos H; Mulet X; Oliver A; Ruiz-Garbajosa P; Canton R
Rev Esp Quimioter; 2024 Feb; 37(1):69-77. PubMed ID: 37882320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
